Back to Journals » Patient Preference and Adherence » Volume 8

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment

Total article views   HTML views PDF downloads Totals
24,538 Dovepress* 18,086+ 2,080 20,166
PubMed Central* 6,452 1,149 7,601
Totals 24,538 3,229 27,767
*Since 21 August 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 0 5

View citations on PubMed Central and Google Scholar